SCR-LIP-000643 · Claim · machine-readable JSON →

Altered estrogen signalling in affected adipose tissue, including an imbalanced estrogen receptor pattern and local aromatase activity, is proposed as a lipedema mechanism.

General proposition consolidated from 8 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
moderate (GRADE)
Evidence
9 source(s)
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

20142026Pathophysiological dilemmas of lipedema — Szél et al. (2014) · consistentLipödem – Grundlagen und aktuelle Thesen zum Pathomechanismus — Wiedner et al. (2018) · consistentLipedema—Pathogenesis, Diagnosis, and Treatment Options (2020) · consistentLipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation — Katzer et al. (2021) · consistentEstrogen as a Contributing Factor to the Development of Lipedema — Al-Ghadban et al. (2021) · consistentImpact of hormones on lipedema development: a systematic literature review — Lüchinger et al. (2026) · consistentLower limb lipoedema - male patient — Vargas (2026) · contextualLipedema: pathophysiological insights and therapeutic strategies — An update for dermatologists (2026) · consistentThe Adipovascular Unit in Lipedema: A Framework for Regional Adipose Tissue Dysregulation. — Faulhaber J, Hanke CW, Barsch M, Sandhofer M. (2026) · contextual

Evidence (9)

Context (PECO)

Populationwomen with lipedema
Conditionlipedema
Exposurehormonal dysregulation (estrogen, GH, adipokines/leptin)
Outcomepathophysiological hypotheses of lipedema development
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Change log